In-Depth

The In-Depth page consists of Insight Articles, Commentaries, C-level Q&As, Discussion Group Reports, and Survey Reports.

Insight Article
Bioanalysis is an important tool to predict the stability and protein degradation in new pharmaceutical products. Can novel prediction methods an alternative to current methods?
Edited by Oliver Picken |
23 June 2022
Bioanalysis
Discussion Group Report
This month the group addressed challenges for lyophilization scale up. The group was led by Claudia Krichbaum, Principal Scientist, Pharmaceutical Technologies, at Merck Healthcare KGaA.
Edited by Oliver Picken |
07 June 2022
Bioanalysis
Insight Article
mRNA delivery techniques took a long time to come to fruition, but recent advancements have enabled production at a scale never seen before.
Edited by Oliver Picken |
06 May 2022
RNA Formulation & Delivery
Insight Article
Despite their advantages, combination products present new technological and organizational challenges. They require new product development strategies compared to standalone products, drugs, and devices.
Edited by Oliver Picken |
05 May 2022
Drug Delivery
Discussion Group Report
While new manufacturing technologies have the potentially to dramatically shift the way the pharmaceutical industry works, many challenges are preventing wider adoption.
Edited by Oliver Picken |
27 April 2022
Drug Formulation
Commentary
Wicked problems – chronic health issues such as diabetes, obesity, and endocrine disorders – are projected to affect close to one billion people worldwide by 2045. By planning ahead and investing in digital healthcare solutions for connected drug delivery, companies such as Novo Nordisk are aiming to meet rising demands for the provision of healthcare as they occur.
10 April 2022
Drug Delivery
Commentary
In this commentary article, we present Axel Becker's insights on the latest techniques governing API particle properties and the processes that dictate the success of drug reception and tablet compression.
Edited by Ben Norris |
22 March 2022
Drug Formulation
Discussion Group Report
This month, the discussion group debated the advantages and disadvantages of different types of inhalers. One key area of interest was current-day challenges with aerosol delivery, which could be addressed through smart inhalers and other innovative new devices.
Edited by Oliver Picken |
17 March 2022
Inhaled Drug Delivery
Insight Article
How do we make the most of new techniques to optimise product development?
Edited by Tom Cohen |
14 February 2022
Formulation & Delivery Series
Discussion Group Report
Beyond the blood–brain barrier, the pulmonary power of nebulisers, and RNA science in the post-COVID era
Edited by Tom Cohen |
11 February 2022
RNA Formulation & Delivery
Insight Article
The pharmaceutical industry has historically taken a cautious approach to most new advancements, but now it is embracing the possibilities of continuous manufacturing technologies. While traditional batch-based processes are still more common, there are several products on the market that have utilized continuous manufacturing practices.
Edited by Oliver Picken |
20 January 2022
Drug Formulation
Insight Article
RNA based therapeutics, particularly mRNA, has been experiencing a period of rapid growth, partly due to the influx of funding for mRNA Covid-19 Vaccines. One area that has the potential to benefit from mRNA vaccines is cancer. There are various techniques that have potential to combat the deadly disease.   
Edited by Oliver Picken |
11 January 2022
RNA Formulation & Delivery
Discussion Group Report
This November, our Formulation Series discussion group focused on the formulation and delivery of inhaled biologics. Oxford Global’s discussion groups bring together a select group of 15-20 key industry leaders for approximately one hour for in depth knowledge sharing and conversation.
Edited by Oliver Picken |
09 December 2021
Inhaled Drug Delivery
Insight Article
Nanomedicine and nanotechnology delivery systems are relatively new but have shown promising results and potential for innovative new drugs.
Edited by Oliver Picken |
23 November 2021
Drug Delivery
Discussion Group Report
This September, our formulation series discussion group focused on the delivery of oral biologics. Biologic-based therapies have soared in popularity and now account for approximately 12% of the pharmaceutical market.
Edited by Oliver Picken |
23 November 2021
Formulation & Delivery Series
Insight Article
In this Insight Article, we delve into the complex intricacies of the Blood-Brain Barrier, explore its challenge for drug delivery, and look at 3 of the most exciting solution technologies.
Edited by Tia Byer |
01 October 2021
Drug Delivery
Insight Article
Can Inhaled Biologics make a comeback?  
Edited by Oliver Picken |
30 September 2021
Inhaled Drug Delivery
Commentary
Exploring advancements in inhalation products with Peter J Barnes.
Edited by Oliver Picken |
30 September 2021
Inhaled Drug Delivery
Commentary
Innovative drug delivery systems create a new paradigm for pharmaceuticals, enabling more efficient and targeted administration.
Edited by Oliver Picken |
24 September 2021
Drug Delivery
Insight Article
In this Insight Article, we delve into the challenges of the gastrointestinal tract for oral peptide delivery and look at 3 of the most promising solution technologies
Edited by Tia Byer |
15 September 2021
Inhaled Drug Delivery
Advertisement

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login